Ipratropium
Overview
Ipratropium is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1621597).
API suppliers (6)
Suppliers of Ipratropium evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
2 of 6 hold a GMP certificate on record in the EU or UK registers
- Amphastar Nanjing PharmaceuticalsChina1 active DMF
- Scl Lifesciences LimitedIndia1 active DMF GMP on record
- BOEHRINGER INGELHEIM PHARMA GMBH AND CO KGGermany1 active DMF
- Neuland Laboratories LimitedIndia1 active DMF
- Cipla USA, Inc.USA
- VAMSI LABS LTDIndia GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (17 approved US products), the latest listed US patent on Ipratropium expires — and exclusivity 13 Oct 2026. Generic API sourcing typically opens up once these lapse.
Do you supply Ipratropium? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.